AN2 Therapeutics, Inc. (ANTX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0373261058
AN2 Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -38.11 m USD |
| EBIT | -38.11 m USD |
| Net income | -35.17 m USD |
| Diluted EPS – continuing operations | -1.16 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis. It also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials; and has various research programs targeting the development of novel compounds in oncology and infectious disease based on its boron chemistry platform. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize compounds and products, including epetraborole for the treatment, diagnosis, or prevention of various human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize compounds and products comprising epetraborole in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases; and GSK plc for the development of new therapies for TB. AN2 Therapeutics, Inc. was incorporated in 2017 and is headquartered in Menlo Park, California.
More stocks
- NRC Group ASA (NRC.OL)
- Fidelix Co. Ltd (032580.KQ)
- United Pharm (033270.KS)
- VINCE HOLDING CORP. (VNCE)
- Donga Geologic (028100.KS)
- OptimizeRx Corp (OPRX)
- Pappajack Bhd (0242.KL)
- Umweltbank (UBK.DE)
- NeoVolta Inc. (NEOV)
- Samba Digital, SGPS, S.A. (ALSMB.LS)
- XChange TEC.INC (XHG)
- Ilshin Spinnin (003200.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.